This session is presented by Lauren MIlls and Joeeta Murphy from iP21 and will explore how IP can be strategically leveraged to drive innovation and commercial success in the Life Sciences sector. From patents protecting cutting-edge biotechnologies and pharmaceuticals to trade marks and design rights supporting brand identity and product differentiation, we’ll examine the key IP tools available to researchers, startups, and established companies. The talk will also cover common pitfalls, ownership issues, collaboration agreements, and the role of software and data in life sciences. Real-world examples and practical guidance will help attendees understand how to build robust IP portfolios and avoid costly missteps on the path to market.